Element appears to be reorganizing its operations around two global business lines—Aero, Space & Defense and Consumer & Industrials—while bolstering leadership and capability in safety‑critical markets.
Public signals include the launch of a 24/7 automated machining centre, an expanded partnership with IMV Corporation, the sale of its North America life‑sciences testing unit, hiring for aerospace programmes and a new Vice President for Europe.
Element launched a 24/7 automated machining centre at its Lancaster laboratory with Mazak, adding CNC machining, robotics and digital traceability to increase sample preparation capacity and support both specialist and large production testing programmes.
Element announced an expanded strategic partnership with IMV Corporation, including investment in 11 dynamics systems across laboratories and further planned systems for Los Angeles and Melbourne, while positioning Huntsville as a U.S. hub for advanced testing.
Eurofins completed the acquisition of Element’s North America life sciences testing services business, indicating Element has exited that unit while reorganizing around other global end markets.
Element is hiring an Additive Manufacturing and Engineering Technician in Greater Indianapolis to operate Direct Energy Deposition systems and support aerospace programs.
Element appointed a Vice President, Europe for its Consumer & Industrials Business Line, strengthening leadership for the second major pillar of the new operating model.
Element appears to be gearing up for a broader commercial push in Europe focused on nuclear, SMR and fusion testing services. The company’s hiring of senior business development staff in the Netherlands and Germany, together with recent product announcements, suggests a coordinated effort to serve the European nuclear supply chain.
Public signs include new roles targeting energy accounts across Europe and a dedicated SMR product qualification capability at its Huntsville lab.
Element is hiring a Business Development Director for Energy Europe in the Netherlands, leading a commercial team and covering cluster strategy, revenue growth, profitability, market intelligence, customer insights, competitive analysis, and cross‑sell/up‑sell across Europe.
Element is hiring a Europe Business Development Director covering Germany and the Netherlands, supporting Mülheim among other sites, with responsibility for Aerospace & Defence and Energy growth across Europe.
Element is hiring a Nuclear Business Development Manager in Mülheim to develop nuclear testing, inspection, and certification services across conventional nuclear power, SMRs, and fusion technologies.
Element announced that the Huntsville expansion enables the launch of dedicated product qualification for small modular reactor programmes, described as a first‑in‑industry capacity linking SMR testing to broader qualification for nuclear, hydrogen and other new technologies.
Element appears to be reshaping its portfolio, placing a sharper emphasis on industrial, aerospace, energy, transportation and related testing services after the recent divestment of its North American life‑sciences testing business.
Public signs include the launch of a 24/7 automated machining centre at its Lancaster laboratory to boost specimen‑preparation capacity and cut lead times for aerospace, energy, transportation and industrial programmes; the completion of Eurofins’ acquisition of Element’s North America Life Sciences Testing Services business, which comprised 27 laboratories, about 750 employees and expected 2026 revenue above USD 150 million; and a transition page confirming that Element retained several medical‑device services such as clinical validation, orthopedic testing, and wireless and battery testing of medical devices.
Element launched a 24/7 automated machining centre at its Lancaster laboratory to increase specimen‑preparation capacity and reduce lead times for aerospace, energy, transportation and industrial testing programs.
Eurofins completed its acquisition of Element’s North America Life Sciences Testing Services business on October 1, 2026, covering 27 laboratories and facilities, about 750 employees and expected 2026 revenue above USD 150 million.
Element’s life‑sciences transition page confirms that the North American life‑sciences laboratories moved to Eurofins, while Element retained several medical‑device services including clinical validation, orthopedic testing, and wireless and battery testing of medical devices.
Paldo wrote this page from the public sources linked above. What a company appears to intend is our reading and may be wrong. If something is out of date, tell us.
